http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2061197-C
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-22 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235 |
filingDate | 1992-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2002-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bce94361f5455b9ecd70a33e9dd33998 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83df6bc5112356e9ebb1527e1a45abba |
publicationDate | 2002-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2061197-C |
titleOfInvention | Salicyloyl carnitine and process for its preparation |
abstract | Novel 3-(2-hydroxybenzoyloxy)-4-(trimethylarnmonio)-butyric acid betaine and its pharmaceutically acceptable salts are disclosed. The compounds are distinguished by high water solubility, minimum toxicity, and good gastric tolerance vis-a-vis acetylsalicylic acid and can be prepared from carnitine hydrochloride and o-methoxybenzoyl chloride. |
priorityDate | 1992-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.